{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-101605","form_type":"8-K","ticker":"BRKR","cik":"0001109354","company_name":"BRUKER CORP","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.363956+00:00","generated_at":"2026-05-17T21:21:33.589769+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Bruker Q2 revenue $797M, -0.4% YoY; non-GAAP EPS $0.32, -38.5%; lowers FY2025 guidance","bullets":["Q2 revenue $797.4M, organic -7.0% YoY from weak US academic and biopharma demand.","GAAP EPS $0.05; non-GAAP EPS $0.32, down 38.5% vs Q2 2024 $0.52.","BSI segment revenue $733.2M (organic -7.2%); BEST segment $66.3M (organic -4.8%).","FY2025 guidance cut: revenue $3.43-3.50B (2-4% reported growth), non-GAAP EPS $1.95-2.05 vs FY2024 $2.41.","Announced expanded cost initiative targeting $100-120M annual savings in FY2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-101605","json":"https://secwatch.observer/filing/0000950170-25-101605.json","markdown":"https://secwatch.observer/filing/0000950170-25-101605.md","text":"https://secwatch.observer/filing/0000950170-25-101605.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109354/000095017025101605/0000950170-25-101605-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109354/000095017025101605/brkr-20250804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:21:33.589769+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}